NET Patient Rob Hammond speaks at the Senate Inquiry hearing in Tasmania

NET Patient and passionate advocate and fundraiser Rob Hammond shared his story and the plight of NET Patients Australia wide at the Senate Inquiry into “Equitable access to diagnosis and treatment for individuals with rare and less common cancers, including neuroendocrine cancer” in Hobart on February 20.

Rob spoke about the challenges around accessing optimal care and the inequities that NET patients face living in Tasmania, including referral pathways, HCP education and low awareness of the disease amongst the general public and healthcare professional community. He touched on the challenges he has faced during this advocacy work and thanked Senator Wendy Askew for the opportunity to speak and feel heard. Thank you Rob for sharing not only your own story, but one that will resonate with so many Tasmanian and NET patients and indeed patients Australia wide.

Listen to Robs full speech here.

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Inherited Cancers Australia Event

Racing for a Cure 2026 – thank you Rob!

NECA Joins Cancer Australia’s Low Survival Cancers Mission Roundtable

NECA CEO Meredith Cummins named Health and Social Services Government Relations Practitioner of the Year

Neuroendocrine Cancer Day

Neuroendocrine Cancer Day is on 10 November, and every bit of support counts.

Create an event, share your artwork, or donate on our ‘Double Your Impact’ days. There are so many ways to stand with the NET community.